Canaccord Genuity Maintains Buy on LifeStance Health Gr, Raises Price Target to $16

Benzinga · 1d ago
Canaccord Genuity analyst Richard Close maintains LifeStance Health Gr (NASDAQ:LFST) with a Buy and raises the price target from $15 to $16.